Glenmark Pharma recieves USFDA approval for Zyvox
Glenmark Pharmaceuticals has received the USFDA final approval for its anti-bacterial drug Zyvox. The product is the therapeutic equivalent of Zyvox tablets, 600 mg of […]
USFDA
Biocon acquires Acacia Lifesciences
Biocon has acquired a manufacturing unit of Acacia Lifesciences in Vizag for an undisclosed amount. The company has acquired business assets of the pharmaceutical manufacturing […]
Granules India receives USFDA approval for Ibuprofen
Granules India has received approval from the USFDA to market generic Ibuprofen tablets in US markets. The Hyderabad-based company said US FDA has approved its […]
Aurobindo Pharma receives approval for Tramadol Hcl
Aurobindo Pharma has received USFDA approval for the drug Tramadol Hydrochloride extended-release tablets, which is used for treating pain for extended period in adults. The […]
Aurobindo Pharma receives USFDA approval for Telmisartan
Aurobindo Pharma has approval from USFDA for the generic drug Telmisartan used in treatment for hypertension. The company has received approval to manufacture and market […]
Aurobindo Pharma receives USFDA approval for Raloxifene Hydrochloride
Aurobindo Pharma has received the final approval from USFDA for Raloxifene Hydrochloride tablets, which is bio-equivalent and therapeutic equivalent to the reference listed drug product […]
Lupin receives USFDA approval for Omeprazole delayed-release capsules 40 mg
Lupin has received final approval from USFDA for its Omeprazole delayed-release capsules 40 mg which is market equivalent of AstraZeneca Prilosec delayed-release capsules 40mg. The […]
Novartis receives USFDA approval for Eltrombopag drug
Novartis has received USFDA approval for eltrombopag drug (Promacta for oral suspension, Novartis) for the treatment of thrombocytopenia in paediatric patients. The approval was based […]
Sun Pharma receives USFDA approval for XiminoTM
Sun Pharmaceutical Industries has received approval from USFDA for its new drug used for acne treatment XiminoTM extended-release capsules in strengths of 45 mg, 90 […]
DRL launches generic Pramipexole dihydrochloride in US market
Dr Reddy’s Laboratories has launched generic Pramipexole dihydrochloride extended-release tablets for treatment of Parkinson’s disease in the US market. The company has launched the tablets […]